David Goel Matrix Capital Management Company
David Goel is a co-founder of Matrix Capital Management, a technology-oriented investment firm with public and private market activities. Matrix is known for concentrated positions in software, semiconductor, and internet-related businesses. Goel’s filings are monitored for high-conviction technology themes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$102M |
| 2 |
NVIDIA
NVDA
|
+$67.1M |
| 3 |
ALTR
Altair Engineering Inc
ALTR
|
+$64.9M |
| 4 |
Moderna
MRNA
|
+$38.2M |
| 5 |
Aura Biosciences
AURA
|
+$13.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$207M |
| 2 |
VTYX
Ventyx Biosciences
VTYX
|
+$3.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 72.47% |
| 2 | Consumer Discretionary | 11.47% |
| 3 | Industrials | 11.4% |
| 4 | Healthcare | 4.31% |
| 5 | Materials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$5.2T
| $1.64B | 16.86% |
33,085,120
+1,448,120
| +5% | +$67.1M |
|
2
Applied Materials
AMAT
$391B
| $1.14B | 11.76% |
7,052,700
| – | – |
|
3
Amazon
AMZN
$2.79T
| $1.11B | 11.47% |
7,335,828
| – | – |
|
4
TransDigm Group
TDG
$66.4B
| $1.11B | 11.4% |
1,094,900
| – | – |
|
5
GlobalFoundries
GFS
$26.4B
| $1.03B | 10.63% |
17,048,000
| – | – |
|
|
ALTR
6
DELISTED
Altair Engineering Inc
ALTR
| $1.03B | 10.6% |
12,233,174
+932,717
| +8% | +$64.9M |
|
|
7
Marvell Technology
MRVL
$213B
| $908M | 9.35% |
15,055,500
+1,888,676
| +14% | +$102M |
|
8
Workday
WDAY
$49.4B
| $438M | 4.51% |
1,586,043
| – | – |
|
9
ASML
ASML
$677B
| $376M | 3.87% |
497,200
| – | – |
|
10
Synopsys
SNPS
$76.2B
| $370M | 3.8% |
717,735
| – | – |
|
11
Zentalis Pharmaceuticals
ZNTL
$363M
| $211M | 2.18% |
13,959,973
| – | – |
|
12
Autodesk
ADSK
$53.6B
| $101M | 1.04% |
414,000
| – | – |
|
|
13
Aura Biosciences
AURA
$809M
| $61.3M | 0.63% |
6,922,870
+1,560,000
| +29% | +$13.2M |
|
14
Adaptive Biotechnologies
ADPT
$4.15B
| $56.7M | 0.58% |
11,572,590
| – | – |
|
|
15
Moderna
MRNA
$57.9B
| $45.2M | 0.46% |
+454,000
| New | +$38.2M |
|
16
Perimeter Solutions
PRM
$5.15B
| $34.3M | 0.35% |
7,462,500
| – | – |
|
|
ADAP
17
DELISTED
Adaptimmune Therapeutics
ADAP
| $30.9M | 0.32% |
38,974,185
| – | – |
|
18
Veeva Systems
VEEV
$40.3B
| $13.1M | 0.13% |
+67,832
| New | +$12.8M |
|
19
Zscaler
ZS
$29.4B
| $4.08M | 0.04% |
18,405
| – | – |
|
|
20
Qualcomm
QCOM
$169B
| – | – |
-1,861,000
| Closed | -$207M |
|
|
VTYX
21
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-89,900
| Closed | -$3.12M |
|
Similar funds
David Goel's Q4 2023 Portfolio in Review
As of Q4 2023, David Goel held 21 positions worth $9.72B, up 17% from $8.34B the previous quarter. Its ten largest holdings account for 94% of the portfolio.
David Goel's Q4 2023 filing shows 2 new, 4 increased and 2 closed positions. Its largest new stake was Moderna: 454,000 shares worth $45.2M. The largest sale was Qualcomm, an estimated $207M.
By sector, the portfolio is most concentrated in Technology at 72% of assets, up from 72% a quarter earlier, followed by Consumer Discretionary and Industrials.
- David Goel's largest Q4 2023 buy was Moderna: 454,000 shares worth $45.2M.
- David Goel added most to Marvell Technology in Q4 2023, an estimated $102M increase.
- David Goel fully exited Qualcomm in Q4 2023, selling an estimated $207M.
- David Goel's ten largest holdings make up 94% of its $9.72B portfolio in Q4 2023.
- David Goel opened 2 new positions and closed 2 in Q4 2023.
- David Goel's portfolio value rose 17% quarter-over-quarter to $9.72B.
Based on Matrix Capital Management Company's 13F filing for Q4 2023, filed 13 Feb 2024.